https://dermatologynews.net/articles/alopecia-areata-oral-jak-inhibitors-2026/ DermatologyNews en 2026-08-01 Oral JAK inhibitors for alopecia areata: FDA labels compared https://dermatologynews.net/articles/clascoterone-cream-acne-evidence-2026/ DermatologyNews en 2026-08-01 Clascoterone for acne: topical antiandrogen evidence https://dermatologynews.net/articles/delgocitinib-chronic-hand-eczema-evidence-2026/ DermatologyNews en 2026-08-01 Delgocitinib for chronic hand eczema: trial evidence https://dermatologynews.net/articles/fda-rf-microneedling-safety-communication-2025/ DermatologyNews en 2026-08-01 FDA RF microneedling safety communication: key facts https://dermatologynews.net/articles/lebrikizumab-nemolizumab-atopic-dermatitis-2026/ DermatologyNews en 2026-08-01 Lebrikizumab and nemolizumab: atopic dermatitis evidence https://dermatologynews.net/articles/ruxolitinib-cream-vitiligo-evidence-2026/ DermatologyNews en 2026-08-01 Ruxolitinib cream for vitiligo: evidence and limits